Current status in intrauterine fetal stem cell therapy.

In utero fetal stem cell transplantation, a today experimental treatment option, represents a new therapeutic strategy with broad implications for diseases related to the hematopoietic system. The object of the present paper is to give a review of the published literature on fetal stem cell therapy with special reference to immunological and strategical considerations. Furthermore, ethical considerations on account of the use of fetal cells are pointed out and a prospective view concerning experimental and clinical future perspectives is presented.